DB05326ExperimentalSmall molecule
INKP-102 is the next generation sodium phosphate tablet designed to aid bowl preparation before colonoscopy.
- Mechanism
- Curator reviewed
INKP-102 tablets are smaller in size and easier to swallow than the Company's currently marketed sodium phosphate tablet product, Visicol. The new INKP-102 tablets contain no microcrystalline cellulose (MCC), an inert, but highly insoluble, tablet binder.
- Primary indication
- Investigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous).Curator reviewed
- Code names
- INKP-102
Which companies are running trials of INKP-102, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account